Long term follow-up of Polycythemia Vera patients treated with imatinib mesylate

被引:0
作者
Jones, C. Michael [1 ]
机构
[1] Jones Clin, Germantown, TN USA
关键词
Imatinib mesylate; Polycythemia Vera; Myeloproliferative disorder; Myeloproliferative neoplasm; Tyrosine kinase inhibitor; Myelosuppressive therapy;
D O I
10.1016/j.leukres.2012.03.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:815 / 816
页数:2
相关论文
共 3 条
  • [1] Phase II open label trial of imatinib in polycythemia rubra vera
    Jones, C. Michael
    Dickinson, Tina M.
    Salvado, August
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (05) : 489 - 494
  • [2] Treatment of polycythemia vera with imatinib mesylate
    Silver, Richard T.
    Bourla, Michael H.
    Vandris, Katherine
    Fruchtman, Steven
    Spivak, Jerry L.
    Feldman, Eric J.
    Salvado, August J.
    [J]. LEUKEMIA RESEARCH, 2012, 36 (02) : 156 - 162
  • [3] Vakil E, 2011, LEUKEMIA S1, V11, pS37